DIMERIX LIMITED - Charts / Financials

6.42%

51.0¢

Market Cap $306.0M

Healthcare Biotechnology

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

ASX:PAR

This stock could have something close to a cure for osteoarthritis. Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.

REFRESH

Last update - 15.59pm 29/07/2025 (20 minute delay)

Day
Open	54.0¢		Day High	54.5¢		Day Low	50.0¢
Daily Volume	5022049

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
2	50.5¢	14200		2	51.0¢	8000

Directors & Senior Management

Dr. Nina Webster	Chief Executive Officer, Managing Director, Director
Mr. Hamish George	Chief Financial Officer, Company Secretary
Dr. David Fuller	Chief Medical Officer
Dr. Ash Soman	Member of the Executive Board
Mr. Mark Diamond	Non-Executive Chairman of the Board
Mr. Hugh Alsop	Non-Executive Director
Dr. Sonia Maria Poli	Non-Executive Director
Mr. Clinton Snow	Non-Executive Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 51.0¢		Change -0.035(6.42%)		Mkt cap ! $306.0M

Open	High	Low	Value	Volume
54.0¢	54.5¢	50.0¢	$2.603M	5.022M

Buyers (Bids)

No.	Vol.	Price($)
2	14200	50.5¢

Sellers (Offers)

Price($)	Vol.	No.
51.0¢	8000	2

View Market Depth

No.	Vol.	Price($)
2	14200	0.505
15	118942	0.500
5	89194	0.495
7	128232	0.490
3	31261	0.485

Price($)	Vol.	No.
0.510	8000	2
0.515	5000	1
0.520	29689	2
0.525	15235	2
0.530	14704	3

Last trade - 16.10pm 29/07/2025 (20 minute delay)


Last 50.0¢		Change -0.035 ( 7.41 %)
Open	High	Low	Volume
54.0¢	54.0¢	50.0¢	1366904
Last updated 15.59pm 29/07/2025 ?

DXB (ASX) Chart

DIMERIX LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories